The extensive regenerative capacity of hepatocytes and the key roles of the
liver in metabolic processes have generated interest in the liver as an ap
propriate target for cell and gene therapy. If cells were considered as nat
ural biomaterials, then liver cell transplantation would fall within the ge
neral field of bioengineering. While unmodified hepatocytes engraft in the
liver and ectopic sites, biological modifications and optimization of bioen
gineered systems would facilitate engraftment and survival of transplanted
cells. especially in ectopic locations. Acute liver failure, chronic Liver
disease and metabolic deficiency states are among the conditions that can p
otentially be treated by cell transplantation. In acute liver failure, cell
transplantation into the liver, along with the creation of an extrahepatic
reservoir of cells might be required because engraftment and proliferation
of transplanted cells in rile liver needs time. In other situations, gradu
al liver repopulation alone might well be effective without additional mani
pulations.